Author: Dena Battle

New first line standard of care treatment for Stage 4 RCC

New data from the pivotal phase 3 Checkmate 214 trial combining ipilumimab and nivolumab presented at the European Society of Medical Oncology (ESMO) conference in Madrid showed superiority for the combination over Sunitinib (Sutent). This data will likely mean that the IO combination will move to approval for first line stage 4 RCC therapy.

KCCure Awards Inaugural Grant of $100,000 to Dana Farber for work in CAR T-Cell Research

The Kidney Cancer Research Alliance (KCCure) announced today that their first research grant of $100,000 has been awarded to Dr. Wayne Marasco, at Dana Farber Cancer Center for his proposal: CAR T-Cell Factories that change the Tumor Microenvironment to Achieve RCC Cures.

Show your colors for World Kidney Cancer Day by helping us fund more research!

For our part, in honor of World Kidney Cancer Day – we are proud to announce that our first grant of $100,000 is being awarded to Dr. Wayne Marasco at Dana Farber Cancer Center for his continuing efforts to translate CAR T-Cell Therapy into a new treatment for kidney cancer.

June 22 is World Kidney Cancer Day!

As members of the International Kidney Cancer Coalition (IKCC), KCCure is a proud partner and participant of the first-ever World Kidney Cancer Q&A Day.  On June 22, 2017, patients, caregivers, health care professionals and local organizations from around the world will join together to raise awareness about kidney cancer.

Take our Survey and help us improve surveillance in Kidney Cancer

Help us improve surveillance in kidney cancer by taking the KCCure kidney cancer survey

KCCure Co-founder Susan Poteat presents to IKCC in Poland

It's hard to believe how far we've come as an organization in less than one year since our launch.  This week, marked another milestone as KCCure was represented, for the first time, at the International Kidney Cancer Coalition Conference (IKCC) in Warsaw, Poland.

Voice of Kidney Cancer – Laura’s story

Laura tells KCCure about her diagnosis with stage 4 papillary kidney cancer and how she now has No Evidence of Disease (NED) from the treatment Cabozantinib. This is her story.

Voice of Kidney Cancer – Holly and Joe

Holly and Joe share a story that is familiar to many of us who have experienced a kidney cancer diagnosis. Delays due to the wrong tests, referrals for complications. But also what it means to patients when doctors communicate effectively and when nurses go above and beyond to save Christmas. Holly and Joe - we are all here cheering you on!

Still Always Yes

KCCure President Dena Battle shares her thoughts on caregiving and grief - and why even after a tough kidney cancer battle, she's still grateful for the past and hopeful for the future.

Voice of Kidney Cancer – Holly Johnston

Holly Johnson, is a stage 4 kidney cancer patient, but she doesn't let herself be defined by her diagnosis. Thank you for lending your voice

March is Kidney Cancer Awareness Month – Join our Facebook Campaign and tell your story!

I’ll be honest, there’s something about the word “awareness” that I’ve never really liked – I think it’s because I wish we didn’t have to be aware of kidney cancer.  And I suppose it makes sense, because our goal at KCCure is to raise money for research to eliminate kidney cancer – to end the need for an awareness month. But for now, there are too many reminders that it sti...

Report from ASCO GU 2017

ASCO GU is an annual symposium where doctors and members of the cancer community gather from around the world to discuss the latest and greatest in research for Genitourinary (GU) Cancers – which includes kidney cancer.  KCCure was honored to be included, along with many other valued advocacy organizations, representing the patient voice.

Lost Password


Subscribe for updates!